OhioHealth is pioneering the treatment of peripheral artery disease -- a condition that affects one in 20 adults over age 50. We are the first in the nation to use a drug-coated stent outside the heart.

PADStents are tiny wire mesh tubes used to keep arteries open following angioplasty. Drug-coated stents, also known as drug-eluting stents, slowly release medication to prevent scar tissue from forming in the arteries. We are the first in the nation to use drug-eluting stents to treat blockages in leg arteries.

We are treating patients with the FDA-approved Zilver PTX stent after leading a national clinical trial that yielded outstanding results. In the clinical trial, eight in ten patients treated with the new stent still had open arteries after one year, compared to three in ten treated with angioplasty alone. In addition, patients who received a bare metal stent required more than twice as many repeat procedures to reopen the artery as patients who received the new stent. It's a revolution in peripheral vascular care, and it's available only at OhioHealth now.

With the development of the new Zilver PTX drug-eluting stent, treatment of PAD in the United States is expected to undergo a revolution akin to the use of drug elution in treating coronary artery disease.

Some signs of PAD include:

  • Pain, numbness, aching, or heaviness in the leg muscles when walking or climbing stairs
  • Cramping in the affected leg(s) and in the buttocks, thighs, calves and feet when walking or climbing stairs
  • Weak or absent pulses in the legs or feet